@article{e787e81e9b9a4918ad6095a9aaef76aa,
title = "Analysis of peripapillary atrophy in relation to macular geographic atrophy in age-related macular degeneration",
abstract = "PURPOSE. The purpose of this study was to investigate the presence, configuration, and progression of peripapillary atrophy (PPA) relative to macular geographic atrophy (GA) in AMD. METHODS. Confocal scanning laser ophthalmoscopy images of 413 eyes of 413 patients with GA secondary to AMD (median age, 77.0 years) were evaluated for the presence and configuration of PPA at baseline. In addition, the progression of PPA and the regression of the shortest linear dimension between PPA and GA ({\textquoteleft}{\textquoteleft}buffer zone{\textquoteright}{\textquoteright}) were assessed in 164 eyes that had completed 12 months of follow-up. RESULTS. At baseline, PPA was present in 357 (86.4%) of 413 eyes, of which 330 eyes (79.9%) were classified as nonconfluent and 27 eyes (6.5%) as confluent PPA. At month 12, eight eyes had transformed from nonconfluent to confluent PPA. The median buffer zone at baseline was significantly smaller in these latter eyes than in eyes where the PPA remained nonconfluent (168.46 vs. 1451.64 lm; P < 0.001). The mean regression rate of the buffer zone was 163.0 lm/y (interquartile range, 77.2–281.3). CONCLUSIONS. Peripapillary atrophy is highly prevalent in eyes with GA due to AMD. Assessment of the buffer zone in eyes with nonconfluent PPA at baseline may be helpful to identify subjects at risk for the progression to confluent PPA. In future interventional clinical trials, it may be useful to exclude any eyes both with confluent PPA at baseline and at risk for development of confluent PPA over time to improve the accuracy of GA lesion size quantification and its enlargement over time.",
keywords = "Age-related macular degeneration, Fundus autofluorescence, Geographic atrophy, Scanning laser ophthalmoscopy",
author = "{the GAP Study Group} and Petrus Chang and Anna Tan and Jaffe, {Glenn J.} and Monika Fleckenstein and Holz, {Frank G.} and Steffen Schmitz-Valckenberg and Agostini, {H. J.} and R. Anand and J. Arnold and F. Bandello and Boyer, {D. S.} and Brown, {D. M.} and D. Callanan and U. Chakravarthy and G. Cowan and S. Downes and R. Guymer and Halperin, {L. S.} and He, {Y. G.} and Heier, {J. S.} and A. Leys and A. Loewenstein and E. Midena and S. Patel and D. Pauleikhoff and A. Pollack and C. Pruente and M. Georgopoulus and Russell, {S. R.} and Sadda, {S. V.} and L. Singerman and Sahel, {J. A.} and S. Mohand-Said and G. Staurenghi and Teske, {M. P.} and A. Tufail and {Von Strachwitz}, C. and Wells, {J. A.} and P. Wiedemann and S. Wolf and U. Wolf-Schnurrbusch",
note = "Funding Information: The GAP Study was sponsored by Alcon Research Ltd. The following Alcon Research Ltd. employees contributed to this study as Clinical Trial Managers: Alberta Davis, Petra Kozma-Wiebe, and Miguel Martinez. Funding Information: Supported by Alcon Laboratories, Inc. (Fort Worth, TX, USA). The GAP Study was funded, designed, and conducted by the sponsor. The primary and secondary study objects are not the aim of the current publication and have been reported elsewhere. The data presented are additional analyses that were conducted without extra funding by the sponsor. The manuscript was reviewed and approved by the sponsor. Disclosure: P. Chang, Heidelberg Engineering (F), Carl Zeiss Meditec AG (F), Optos (F); A. Tan, Heidelberg Engineering (F), Carl Zeiss Meditec AG (F), Optos (F); G.J. Jaffe, Alcon/Novartis Publisher Copyright: {\textcopyright} 2016 Association for Research in Vision and Ophthalmology Inc.. All rights reserved.",
year = "2016",
month = apr,
doi = "10.1167/IOVS.15-18629",
language = "English (US)",
volume = "57",
pages = "2277--2282",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "4",
}